Wave Life Sciences Initiates Clinical Development of WVE-210201 in Patients with Duchenne Muscular Dystrophy

Wednesday, July 11, 2018 1 min read

Key Takeaway: Wave Life Sciences Initiates Clinical Development of WVE-210201 in Patients with Duchenne Muscular Dystrophy

Full Press Release Details

Wave Life Sciences Initiates Clinical Development of WVE-210201 in Patients with Duchenne Muscular Dystrophy.